| 靶点: |
Ca2+ channel |
| 体内研究: |
用 MRS1845 (10 μM) 处理实际上破坏了 β-甘油磷酸盐对钙库操纵的 Ca2+ 进入 (SOCE)的影响。 MRS1845 (10 μM) 显著降低 SOCE,并几乎消除胎盘生长因子 (PlGF) 处理后 SOCE 的增加。 |
| 参考文献: |
1. Harper JL, et al. Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem Pharmacol. 2003 Feb 1;65(3):329-38. 2. Ma K, et al. Phosphate-induced ORAI1 expression and store-operated Ca2+ entry in aortic smooth muscle cells. J Mol Med (Berl). 2019 Oct;97(10):1465-1475. 3. Abdelazeem KNM, et al. Upregulation of Orai1 and STIM1 expression as well as store-operated Ca2+ entry in ovary carcinoma cells by placental growth factor. Biochem Biophys Res Commun. 2019 May 7;512(3):467-472. |
| 溶解性: |
DMSO: 13 mg/mL at 60 °C, soluble |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.51 ml |
12.55 ml |
25.1 ml |
| 5 mM |
0.502 ml |
2.51 ml |
5.02 ml |
| 10 mM |
0.251 ml |
1.255 ml |
2.51 ml |
| 50 mM |
0.05 ml |
0.251 ml |
0.502 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |